首页 > 最新文献

Clinical Endocrinology最新文献

英文 中文
Responses to Comment on ‘Second Primary Papillary Thyroid Carcinoma: Insights From Competing Risk Analysis and Post-RAIT’ 对“第二原发性甲状腺乳头状癌:来自竞争风险分析和后rait的见解”评论的回复。
IF 2.4 3区 医学 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-09-24 DOI: 10.1111/cen.70043
Mingjun Wang, Wenjie Chen, Peiheng Li, Yanping Gong
{"title":"Responses to Comment on ‘Second Primary Papillary Thyroid Carcinoma: Insights From Competing Risk Analysis and Post-RAIT’","authors":"Mingjun Wang, Wenjie Chen, Peiheng Li, Yanping Gong","doi":"10.1111/cen.70043","DOIUrl":"10.1111/cen.70043","url":null,"abstract":"","PeriodicalId":10346,"journal":{"name":"Clinical Endocrinology","volume":"104 1","pages":""},"PeriodicalIF":2.4,"publicationDate":"2025-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145136612","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comment on ‘Second Primary Papillary Thyroid Carcinoma: Insights From Competing Risk Analysis and Post-RAIT’ 第二原发性甲状腺乳头状癌:来自竞争风险分析和后rait的见解。
IF 2.4 3区 医学 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-09-23 DOI: 10.1111/cen.70040
Ahmet Necati Sanli, Deniz Esin Tekcan Sanli
{"title":"Comment on ‘Second Primary Papillary Thyroid Carcinoma: Insights From Competing Risk Analysis and Post-RAIT’","authors":"Ahmet Necati Sanli, Deniz Esin Tekcan Sanli","doi":"10.1111/cen.70040","DOIUrl":"10.1111/cen.70040","url":null,"abstract":"","PeriodicalId":10346,"journal":{"name":"Clinical Endocrinology","volume":"104 1","pages":""},"PeriodicalIF":2.4,"publicationDate":"2025-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145130189","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Catch-Up Growth in Children With Congenital Hypothyroidism on Thyroxine Therapy: A Retrospective Study 甲状腺素治疗对先天性甲状腺功能减退儿童追赶性生长的影响:一项回顾性研究。
IF 2.4 3区 医学 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-09-23 DOI: 10.1111/cen.70038
Preeti Singh, Smriti Rohtagi, Rajeev Kumar Malhotra, Anju Seth

Background and Objective

Despite advances in neonatal care, delayed diagnosis and treatment of congenital hypothyroidism (CH) remain prevalent in regions lacking universal screening. This retrospective study evaluated catch-up growth patterns in 65 children with a delayed diagnosis of CH. Study children were stratified into four groups based on age at thyroxine initiation: Groups A (< 1 year), B (1–<3 years), C (3–<5 years), and D (5–10 years).

Measurements

Growth outcomes, in terms of serial height z scores, skeletal maturation, proportion achieving catch-up growth, and time to catch-up, were assessed at baseline and after 3 years of thyroxine.

Results

Within 3 years of treatment initiation, 64.6% (42/65) of children achieved complete catch-up in linear growth, and 56.9% (37/65) attained optimum catch-up. Among those treated before 1 year of age (Group A), 76% (19/25) achieved complete and optimum catch-up over a median (IQR) duration of 22 [12–33] months. In children diagnosed after 1 year of age (Groups B–D combined), 57.5% (23/40) attained complete catch-up, of whom 78.3% (18/23) achieved optimum growth, with time to catch-up increasing progressively with later age at diagnosis (median range—25–34 months). The greatest change in height z-scores was observed in the first-year post-treatment across all groups, with a decline thereafter. Catch-up in skeletal maturation was observed in 72.3% (47/65) of children and occurred earlier than catch-up in linear growth.

Conclusion

Early thyroxine initiation in CH is critical for optimal linear and skeletal growth. Delayed diagnosis is associated with slower, suboptimal recovery and an increased risk of compromised final adult height.

背景和目的:尽管新生儿护理取得了进展,但在缺乏普遍筛查的地区,先天性甲状腺功能减退症(CH)的诊断和治疗延迟仍然很普遍。本回顾性研究评估了65例迟发诊断为CH的儿童的追赶生长模式。研究儿童根据开始使用甲状腺激素时的年龄分为四组:a组(测量:在基线和使用甲状腺激素3年后,根据连续身高z评分、骨骼成熟度、达到追赶生长的比例和追赶时间来评估生长结果)。结果:在开始治疗的3年内,64.6%(42/65)的儿童实现了线性生长的完全追赶,56.9%(37/65)的儿童实现了最佳追赶。在1岁前治疗的患者(A组)中,76%(19/25)在22[12-33]个月的中位(IQR)持续时间内实现了完全和最佳的追赶。在1岁后诊断的儿童中(B-D组合并),57.5%(23/40)达到完全追赶,其中78.3%(18/23)达到最佳生长,随着诊断年龄的增加,追赶时间逐渐增加(中位范围为25-34个月)。所有组在治疗后第一年观察到高度z分数的最大变化,此后下降。在72.3%(47/65)的儿童中观察到骨骼成熟的追赶,并且发生在线性生长的追赶之前。结论:甲状腺素的早期启动对cha的线形和骨骼生长至关重要。延迟诊断与较慢的、次优的恢复和最终成人身高受损的风险增加有关。
{"title":"Catch-Up Growth in Children With Congenital Hypothyroidism on Thyroxine Therapy: A Retrospective Study","authors":"Preeti Singh,&nbsp;Smriti Rohtagi,&nbsp;Rajeev Kumar Malhotra,&nbsp;Anju Seth","doi":"10.1111/cen.70038","DOIUrl":"10.1111/cen.70038","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background and Objective</h3>\u0000 \u0000 <p>Despite advances in neonatal care, delayed diagnosis and treatment of congenital hypothyroidism (CH) remain prevalent in regions lacking universal screening. This retrospective study evaluated catch-up growth patterns in 65 children with a delayed diagnosis of CH. Study children were stratified into four groups based on age at thyroxine initiation: Groups A (&lt; 1 year), B (1–&lt;3 years), C (3–&lt;5 years), and D (5–10 years).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Measurements</h3>\u0000 \u0000 <p>Growth outcomes, in terms of serial height <i>z</i> scores, skeletal maturation, proportion achieving catch-up growth, and time to catch-up, were assessed at baseline and after 3 years of thyroxine.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Within 3 years of treatment initiation, 64.6% (42/65) of children achieved complete catch-up in linear growth, and 56.9% (37/65) attained optimum catch-up. Among those treated before 1 year of age (Group A), 76% (19/25) achieved complete and optimum catch-up over a median (IQR) duration of 22 [12–33] months. In children diagnosed after 1 year of age (Groups B–D combined), 57.5% (23/40) attained complete catch-up, of whom 78.3% (18/23) achieved optimum growth, with time to catch-up increasing progressively with later age at diagnosis (median range—25–34 months). The greatest change in height <i>z</i>-scores was observed in the first-year post-treatment across all groups, with a decline thereafter. Catch-up in skeletal maturation was observed in 72.3% (47/65) of children and occurred earlier than catch-up in linear growth.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>Early thyroxine initiation in CH is critical for optimal linear and skeletal growth. Delayed diagnosis is associated with slower, suboptimal recovery and an increased risk of compromised final adult height.</p>\u0000 </section>\u0000 </div>","PeriodicalId":10346,"journal":{"name":"Clinical Endocrinology","volume":"104 2","pages":"160-166"},"PeriodicalIF":2.4,"publicationDate":"2025-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145130261","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Guiding Management of Bethesda V Thyroid Nodules: The Role of Molecular Testing Bethesda V型甲状腺结节的指导治疗:分子检测的作用。
IF 2.4 3区 医学 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-09-18 DOI: 10.1111/cen.70032
Idit Tessler, Grégoire B. Morand, Nir A. Gecel, Arad Dotan, Tzahi Yamin, Eran E. Alon, Richard J. Payne, Galit Avior

Objective

The 2023 Bethesda System update introduced molecular testing as a management option for Bethesda V cytology nodules, aiming to guide surgical decision-making. This study investigates the correlation between molecular profiling and malignancy aggressiveness.

Design

We conducted a retrospective multicenter study involving patients with Bethesda V cytology and confirmed malignant pathology who underwent molecular profiling between 2018 and 2021.

Patients

A total of 156 patients with Bethesda V cytology and final malignant histology were included.

Measurements

Malignancy aggressiveness was assessed based on histopathological features following 2015 ATA guidelines. Demographic data, pathology results, and genetic variants were analyzed. Molecular profiling results were stratified according to variant risk levels.

Results

We identified 161 Bethesda V nodules, of which 153 (95.0%) were malignant on final pathology. Genetic stratification revealed no detected mutations in 39.7% (n = 56), low-risk (n = 49, 31.4%), and intermediate-risk variants (n = 45, 28.8%). Only one patient had a high-risk variant. Patients with intermediate-risk variants had a sixfold risk of aggressive disease compared to those with low-risk variants (49% vs. 8.2%, p < 0.001). RAS mutations were the most common among the low-risk group (68.8%) and BRAF V600E predominated in the intermediate-risk group (93.3%).

Conclusions

Our findings suggest that molecular profiling offers insights into risk stratification for Bethesda V thyroid lesions, demonstrating a very low incidence of aggressive pathology in the low-risk molecular group.

目的:2023年Bethesda系统更新引入分子检测作为Bethesda V细胞学结节的管理选择,旨在指导手术决策。本研究探讨分子谱与恶性肿瘤侵袭性的关系。设计:我们进行了一项回顾性多中心研究,涉及2018年至2021年期间接受Bethesda V细胞学检查并确认恶性病理的患者。患者:共纳入156例Bethesda V细胞学检查和最终恶性组织学检查的患者。测量方法:根据2015年ATA指南的组织病理学特征评估恶性肿瘤侵袭性。分析了人口统计数据、病理结果和遗传变异。分子分析结果根据不同的风险水平分层。结果:我们发现161例Bethesda V型结节,其中153例(95.0%)最终病理为恶性。遗传分层显示,39.7% (n = 56)、低危(n = 49, 31.4%)和中危变异(n = 45, 28.8%)未检测到突变。只有一名患者携带高危变异基因。中危变异体患者发生侵袭性疾病的风险是低危变异体患者的6倍(49% vs. 8.2%)。结论:我们的研究结果表明,分子谱分析为Bethesda V型甲状腺病变的风险分层提供了见解,表明低危分子组的侵袭性病理发生率非常低。
{"title":"Guiding Management of Bethesda V Thyroid Nodules: The Role of Molecular Testing","authors":"Idit Tessler,&nbsp;Grégoire B. Morand,&nbsp;Nir A. Gecel,&nbsp;Arad Dotan,&nbsp;Tzahi Yamin,&nbsp;Eran E. Alon,&nbsp;Richard J. Payne,&nbsp;Galit Avior","doi":"10.1111/cen.70032","DOIUrl":"10.1111/cen.70032","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objective</h3>\u0000 \u0000 <p>The 2023 Bethesda System update introduced molecular testing as a management option for Bethesda V cytology nodules, aiming to guide surgical decision-making. This study investigates the correlation between molecular profiling and malignancy aggressiveness.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Design</h3>\u0000 \u0000 <p>We conducted a retrospective multicenter study involving patients with Bethesda V cytology and confirmed malignant pathology who underwent molecular profiling between 2018 and 2021.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Patients</h3>\u0000 \u0000 <p>A total of 156 patients with Bethesda V cytology and final malignant histology were included.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Measurements</h3>\u0000 \u0000 <p>Malignancy aggressiveness was assessed based on histopathological features following 2015 ATA guidelines. Demographic data, pathology results, and genetic variants were analyzed. Molecular profiling results were stratified according to variant risk levels.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>We identified 161 Bethesda V nodules, of which 153 (95.0%) were malignant on final pathology. Genetic stratification revealed no detected mutations in 39.7% (<i>n</i> = 56), low-risk (<i>n</i> = 49, 31.4%), and intermediate-risk variants (<i>n</i> = 45, 28.8%). Only one patient had a high-risk variant. Patients with intermediate-risk variants had a sixfold risk of aggressive disease compared to those with low-risk variants (49% vs. 8.2%, <i>p</i> &lt; 0.001). <i>RAS</i> mutations were the most common among the low-risk group (68.8%) and <i>BRAF V600E</i> predominated in the intermediate-risk group (93.3%).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>Our findings suggest that molecular profiling offers insights into risk stratification for Bethesda V thyroid lesions, demonstrating a very low incidence of aggressive pathology in the low-risk molecular group.</p>\u0000 </section>\u0000 </div>","PeriodicalId":10346,"journal":{"name":"Clinical Endocrinology","volume":"104 1","pages":"67-74"},"PeriodicalIF":2.4,"publicationDate":"2025-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/cen.70032","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145079778","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mass Spectrometric Measurements of 11-Deoxycortisol, Androstenedione and Dehydroepiandrosterone Are Superior to Cortisol to Assess Selectivity of Non-Stimulated Adrenal Vein Sampling 质谱测量11-脱氧皮质醇、雄烯二酮和脱氢表雄酮优于皮质醇,以评估非刺激肾上腺静脉取样的选择性。
IF 2.4 3区 医学 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-09-16 DOI: 10.1111/cen.70037
Francesco Alessi, Christina Pamporaki, Mirko Peitzsch, Georgiana Constantinescu, Hanna Remde, Lydia Kürzinger, Carmina T. Fuss, Manuel Schulze, Sybille Fuld, Sradha Kotwal, Jun Yang, Martin Reincke, Felix Beuschlein, Jacques W. M. Lenders, Graeme Eisenhofer

Objective

Successful adrenal venous sampling (AVS) is traditionally assessed using the ratio of cortisol in adrenal to peripheral venous plasma to calculate the selectivity index. With mass spectrometry other steroids can be simultaneously measured that may improve numbers of apparent successful sampling procedures.

Design

Cross-sectional multicenter study.

Patients

The study involved 229 patients who underwent unstimulated AVS for subtyping primary aldosteronism.

Measurements

Adrenal and peripheral venous plasma cortisol, 11-deoxycortisol, androstenedione and dehydroepiandrosterone were measured by mass spectrometry to assess AVS selectivity. Ratios of aldosterone, measured by mass spectrometry, to each of the four steroids in right versus left adrenal venous plasma were used to assess lateralisation.

Results

Selectivity indices for 11-deoxycortisol, androstenedione and dehydroepiandrosterone were respectively 5.7–(CI 5.1–6.2), 5.1–(CI 4.8–5.4) and 5.9–(CI 5.5–6.4) fold higher (p < 0.0001) than for cortisol. At selectivity index cut-offs of ≥ 3 and ≥ 2, rates of bilateral successful AVS were respectively 91% and 93% for 11-deoxycortisol, 90% and 91% for androstenedione and 89% and 91% for dehydroepiandrosterone, all higher (p < 0.0001) than the 69% and 85% respective success rates for cortisol. With 11-deoxycortisol, rates of apparent unsuccessful AVS procedures were reduced by 54%–72% compared to use of cortisol. There were no clear advantages of any single steroid over the others to assess lateralized aldosterone secretion.

Conclusions

11-Deoxycortisol, androstenedione and dehydroepiandrosterone are more suitable biomarkers than cortisol to assess AVS selectivity and allow rescue of many procedures otherwise deemed unsuccessful. Measurements of cortisol to assess AVS selectivity are best replaced by mass spectrometric measurements of other steroids.

目的:肾上腺静脉取样(AVS)成功与否的传统评价是采用肾上腺皮质与外周静脉血浆中皮质醇的比值来计算选择指数。使用质谱法可以同时测量其他类固醇,这可能会增加明显成功采样程序的数量。设计:横断面多中心研究。患者:该研究涉及229例因原发性醛固酮增多症分型而接受无刺激AVS治疗的患者。测量方法:采用质谱法测定肾上腺和外周静脉血浆皮质醇、11-脱氧皮质醇、雄烯二酮和脱氢表雄酮,以评估AVS的选择性。用质谱法测量左、右肾上腺静脉血浆中醛固酮与四种类固醇的比值,以评估偏侧性。结果:11-去氧皮质醇、雄烯二酮和脱氢表雄酮的选择性指数分别高出5.7-(CI 5.1-6.2)、5.1-(CI 4.8-5.4)和5.9-(CI 5.5-6.4)倍(p)。结论:11-去氧皮质醇、雄烯二酮和脱氢表雄酮是比皮质醇更适合评估AVS选择性的生物标志物,并允许挽救许多被认为不成功的手术。评估AVS选择性的皮质醇测量最好由其他类固醇的质谱测量代替。
{"title":"Mass Spectrometric Measurements of 11-Deoxycortisol, Androstenedione and Dehydroepiandrosterone Are Superior to Cortisol to Assess Selectivity of Non-Stimulated Adrenal Vein Sampling","authors":"Francesco Alessi,&nbsp;Christina Pamporaki,&nbsp;Mirko Peitzsch,&nbsp;Georgiana Constantinescu,&nbsp;Hanna Remde,&nbsp;Lydia Kürzinger,&nbsp;Carmina T. Fuss,&nbsp;Manuel Schulze,&nbsp;Sybille Fuld,&nbsp;Sradha Kotwal,&nbsp;Jun Yang,&nbsp;Martin Reincke,&nbsp;Felix Beuschlein,&nbsp;Jacques W. M. Lenders,&nbsp;Graeme Eisenhofer","doi":"10.1111/cen.70037","DOIUrl":"10.1111/cen.70037","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objective</h3>\u0000 \u0000 <p>Successful adrenal venous sampling (AVS) is traditionally assessed using the ratio of cortisol in adrenal to peripheral venous plasma to calculate the selectivity index. With mass spectrometry other steroids can be simultaneously measured that may improve numbers of apparent successful sampling procedures.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Design</h3>\u0000 \u0000 <p>Cross-sectional multicenter study.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Patients</h3>\u0000 \u0000 <p>The study involved 229 patients who underwent unstimulated AVS for subtyping primary aldosteronism.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Measurements</h3>\u0000 \u0000 <p>Adrenal and peripheral venous plasma cortisol, 11-deoxycortisol, androstenedione and dehydroepiandrosterone were measured by mass spectrometry to assess AVS selectivity. Ratios of aldosterone, measured by mass spectrometry, to each of the four steroids in right versus left adrenal venous plasma were used to assess lateralisation.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Selectivity indices for 11-deoxycortisol, androstenedione and dehydroepiandrosterone were respectively 5.7–(CI 5.1–6.2), 5.1–(CI 4.8–5.4) and 5.9–(CI 5.5–6.4) fold higher (<i>p</i> &lt; 0.0001) than for cortisol. At selectivity index cut-offs of ≥ 3 and ≥ 2, rates of bilateral successful AVS were respectively 91% and 93% for 11-deoxycortisol, 90% and 91% for androstenedione and 89% and 91% for dehydroepiandrosterone, all higher (<i>p</i> &lt; 0.0001) than the 69% and 85% respective success rates for cortisol. With 11-deoxycortisol, rates of apparent unsuccessful AVS procedures were reduced by 54%–72% compared to use of cortisol. There were no clear advantages of any single steroid over the others to assess lateralized aldosterone secretion.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>11-Deoxycortisol, androstenedione and dehydroepiandrosterone are more suitable biomarkers than cortisol to assess AVS selectivity and allow rescue of many procedures otherwise deemed unsuccessful. Measurements of cortisol to assess AVS selectivity are best replaced by mass spectrometric measurements of other steroids.</p>\u0000 </section>\u0000 </div>","PeriodicalId":10346,"journal":{"name":"Clinical Endocrinology","volume":"104 1","pages":"10-18"},"PeriodicalIF":2.4,"publicationDate":"2025-09-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/cen.70037","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145074612","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Congenital Hypothyroidism: Long-Term Growth and Intellectual Outcomes With a Lower Initial Levothyroxine Dose 先天性甲状腺功能减退:低初始左甲状腺素剂量的长期生长和智力结果。
IF 2.4 3区 医学 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-09-15 DOI: 10.1111/cen.70034
Jun-Hong Park, Jae Hyuk Oh, Min Hyung Cho, Young Suk Shim, Hae Sang Lee

Objectives

This study aims to review the long-term outcome of congenital hypothyroidism (CH) and whether patient- or treatment-related factors impact the outcomes, especially focusing on the initial Levothyroxine dose.

Methods

This is a retrospective, cross-sectional study of the children diagnosed with CH who received Levothyroxine at Ajou University Hospital between 2003 and 2024. Comparative analysis was performed between the low (<10 mcg/kg) and high (≥10 mcg/kg) initial dose groups. Repeated-measures analysis of covariance was employed to evaluate longitudinal changes in growth outcomes, and multivariate linear regression was utilised to evaluate the effects of clinical factors on the intelligence quotient (IQ).

Results

Among the study population, 84 of 144 children were prescribed an initial low dose of Levothyroxine. Most children in both initial dose groups showed appropriate growth within the normal range in the biennial growth evaluation from ages four to eight and in the Wechsler IQ exam. The initial dose seemed to not significantly affect the growth outcomes over time, as no significant differences between the low- and high-dose groups were observed (p values: 0.545, 0.609, 0.532, and 0.501 for bone age—chronological age, height z-score, weight z-score, and BMI z-score, respectively). The effect of the initial dose group on the full-scale IQ was also not statistically significant (p = 0.362).

Conclusion

We demonstrated the favourable long-term outcomes in linear growth and neurodevelopment among children with CH, even in lower initial Levothyroxine doses.

目的:本研究旨在回顾先天性甲状腺功能减退症(CH)的长期预后,以及患者或治疗相关因素是否会影响预后,特别关注左旋甲状腺素的初始剂量。方法:对2003年至2024年间在亚洲大学附属医院接受左甲状腺素治疗的诊断为CH的儿童进行回顾性横断面研究。结果:在研究人群中,144名儿童中有84名最初使用了低剂量的左甲状腺素。两个初始剂量组的大多数儿童在4至8岁的两年一次的生长评估和韦氏智商测试中都显示出在正常范围内的适当生长。随着时间的推移,初始剂量似乎对生长结果没有显著影响,因为在低剂量组和高剂量组之间没有观察到显著差异(骨龄-实足年龄、身高z-评分、体重z-评分和BMI z-评分的p值分别为0.545、0.609、0.532和0.501)。初始剂量组对全量表智商的影响也无统计学意义(p = 0.362)。结论:即使初始左甲状腺素剂量较低,我们也证明了CH患儿线性生长和神经发育的有利长期结果。
{"title":"Congenital Hypothyroidism: Long-Term Growth and Intellectual Outcomes With a Lower Initial Levothyroxine Dose","authors":"Jun-Hong Park,&nbsp;Jae Hyuk Oh,&nbsp;Min Hyung Cho,&nbsp;Young Suk Shim,&nbsp;Hae Sang Lee","doi":"10.1111/cen.70034","DOIUrl":"10.1111/cen.70034","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objectives</h3>\u0000 \u0000 <p>This study aims to review the long-term outcome of congenital hypothyroidism (CH) and whether patient- or treatment-related factors impact the outcomes, especially focusing on the initial Levothyroxine dose.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>This is a retrospective, cross-sectional study of the children diagnosed with CH who received Levothyroxine at Ajou University Hospital between 2003 and 2024. Comparative analysis was performed between the low (&lt;10 mcg/kg) and high (≥10 mcg/kg) initial dose groups. Repeated-measures analysis of covariance was employed to evaluate longitudinal changes in growth outcomes, and multivariate linear regression was utilised to evaluate the effects of clinical factors on the intelligence quotient (IQ).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Among the study population, 84 of 144 children were prescribed an initial low dose of Levothyroxine. Most children in both initial dose groups showed appropriate growth within the normal range in the biennial growth evaluation from ages four to eight and in the Wechsler IQ exam. The initial dose seemed to not significantly affect the growth outcomes over time, as no significant differences between the low- and high-dose groups were observed (<i>p</i> values: 0.545, 0.609, 0.532, and 0.501 for bone age—chronological age, height <i>z</i>-score, weight <i>z</i>-score, and BMI <i>z</i>-score, respectively). The effect of the initial dose group on the full-scale IQ was also not statistically significant (<i>p</i> = 0.362).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>We demonstrated the favourable long-term outcomes in linear growth and neurodevelopment among children with CH, even in lower initial Levothyroxine doses.</p>\u0000 </section>\u0000 </div>","PeriodicalId":10346,"journal":{"name":"Clinical Endocrinology","volume":"103 6","pages":"895-905"},"PeriodicalIF":2.4,"publicationDate":"2025-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/cen.70034","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145063439","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalence of Hypertension in Obese Adolescents With Polycystic Ovary Syndrome 肥胖青少年多囊卵巢综合征高血压患病率
IF 2.4 3区 医学 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-09-14 DOI: 10.1111/cen.70035
Asim Abbas, Aida Vahidi, Mastaneh Moghtaderi

Background

Hypertension (HTN) is one of the most common diseases all over the world. HTN in young females is more common than in males because of the presence of some underlying disease, such as polycystic ovary syndrome (PCOS). PCOS is ubiquitous in adolescent girls and may induce sex hormone imbalances.

Methods

We studied the prevalence of HTN in adolescent girls suffering PCOS referred to the clinic during 1 year. This is a cross-sectional descriptive study investigating the clinical and paraclinical parameters of patients diagnosed with PCOS who were referred to our clinic in 2021. A checklist containing information on demographic findings, history, physical examination, clinical manifestations, and laboratory test results is used to collect patients' data.

Results

Forty-five patients, 11 to 18 years old (mean 16 years), fulfilled PCOS criteria and enrolled in this study. The minimum and maximum systolic blood pressure of patients were 90 and 140 mmHg (mean 111 mmHg, standard deviation: 14.44), and the minimum and maximum diastolic blood pressure were 60 and 90 mmHg (mean 72 mmHg, standard deviation: 14.44). Five patients (11.1%) had HTN by definition, and the mean BMI was 28.1 (standard deviation: 8.3). Echocardiography showed LVH in 4 (8.9%) of patients, and 2 (4.4%) of the patients had hyperlipidemia. Other related findings were increased unwanted hair growth in 31 (68%), depression and anxiety diagnosed according to criteria and by psychiatric consultation in 22 (48.9%) cases, cardiovascular problems in 6 (13.3%) cases, diabetes mellitus in 7 (15.6%) of patients according to ADA 2018 guidelines, hypothyroidism in 4 (8.9%) and asthma in 6 (13.3%) of patients.

Conclusion

Although this study is a small one and was done in a single center, it supports the importance of PCOS in adolescent girls associated with or predisposing to other diseases such as HTN. Careful evaluation and close observation of these patients is critical because early diagnosis and management can prevent late and serious complications.

背景:高血压(HTN)是世界上最常见的疾病之一。HTN在年轻女性中比男性更常见,因为存在一些潜在的疾病,如多囊卵巢综合征(PCOS)。多囊卵巢综合征在青春期女孩中普遍存在,并可能导致性激素失衡。方法:对就诊1年的PCOS少女HTN患病率进行研究。这是一项横断面描述性研究,调查了2021年转介到我们诊所的诊断为PCOS的患者的临床和临床旁参数。一份包含人口学调查结果、病史、体格检查、临床表现和实验室检测结果信息的检查表用于收集患者数据。结果:45例患者符合PCOS标准,年龄11 ~ 18岁(平均16岁),纳入本研究。患者最小和最大收缩压分别为90和140 mmHg(平均111 mmHg,标准差:14.44),最小和最大舒张压分别为60和90 mmHg(平均72 mmHg,标准差:14.44)。5例(11.1%)定义为HTN,平均BMI为28.1(标准差:8.3)。超声心动图显示LVH 4例(8.9%),高脂血症2例(4.4%)。其他相关发现包括:31例(68%)患者多余毛发增加,22例(48.9%)患者根据标准和精神咨询诊断为抑郁和焦虑,6例(13.3%)患者有心血管问题,7例(15.6%)患者根据ADA 2018指南患有糖尿病,4例(8.9%)患者甲状腺功能减退,6例(13.3%)患者患有哮喘。结论:虽然这项研究是在一个单一中心进行的小型研究,但它支持PCOS在与其他疾病(如HTN)相关或易感的青春期女孩中的重要性。仔细评估和密切观察这些患者是至关重要的,因为早期诊断和管理可以预防晚期和严重的并发症。
{"title":"Prevalence of Hypertension in Obese Adolescents With Polycystic Ovary Syndrome","authors":"Asim Abbas,&nbsp;Aida Vahidi,&nbsp;Mastaneh Moghtaderi","doi":"10.1111/cen.70035","DOIUrl":"10.1111/cen.70035","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Hypertension (HTN) is one of the most common diseases all over the world. HTN in young females is more common than in males because of the presence of some underlying disease, such as polycystic ovary syndrome (PCOS). PCOS is ubiquitous in adolescent girls and may induce sex hormone imbalances.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>We studied the prevalence of HTN in adolescent girls suffering PCOS referred to the clinic during 1 year. This is a cross-sectional descriptive study investigating the clinical and paraclinical parameters of patients diagnosed with PCOS who were referred to our clinic in 2021. A checklist containing information on demographic findings, history, physical examination, clinical manifestations, and laboratory test results is used to collect patients' data.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Forty-five patients, 11 to 18 years old (mean 16 years), fulfilled PCOS criteria and enrolled in this study. The minimum and maximum systolic blood pressure of patients were 90 and 140 mmHg (mean 111 mmHg, standard deviation: 14.44), and the minimum and maximum diastolic blood pressure were 60 and 90 mmHg (mean 72 mmHg, standard deviation: 14.44). Five patients (11.1%) had HTN by definition, and the mean BMI was 28.1 (standard deviation: 8.3). Echocardiography showed LVH in 4 (8.9%) of patients, and 2 (4.4%) of the patients had hyperlipidemia. Other related findings were increased unwanted hair growth in 31 (68%), depression and anxiety diagnosed according to criteria and by psychiatric consultation in 22 (48.9%) cases, cardiovascular problems in 6 (13.3%) cases, diabetes mellitus in 7 (15.6%) of patients according to ADA 2018 guidelines, hypothyroidism in 4 (8.9%) and asthma in 6 (13.3%) of patients.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>Although this study is a small one and was done in a single center, it supports the importance of PCOS in adolescent girls associated with or predisposing to other diseases such as HTN. Careful evaluation and close observation of these patients is critical because early diagnosis and management can prevent late and serious complications.</p>\u0000 </section>\u0000 </div>","PeriodicalId":10346,"journal":{"name":"Clinical Endocrinology","volume":"104 1","pages":"47-52"},"PeriodicalIF":2.4,"publicationDate":"2025-09-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145063437","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association Between Serum Uric Acid to Creatinine Ratio and Time in Range in Patients With Type 2 Diabetes 2型糖尿病患者血清尿酸/肌酐比值与时间范围的关系
IF 2.4 3区 医学 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-09-14 DOI: 10.1111/cen.70036
Yu Gong, Ying Li, Qianqian Zhang, Zhangxiang Zhu, Guojuan Wang

Background

Elevated serum uric acid (SUA) levels are an important marker of metabolic disorders. However, SUA levels largely depend on renal clearance function. This study aims to investigate the correlation between serum uric acid to creatinine (SUA/SCr) ratio and time in range (TIR) in patients with type 2 diabetes mellitus (T2DM).

Methods

TIR was assessed using continuous glucose monitoring (CGM) systems in 514 hospitalized patients with T2DM. Biochemical parameters, including blood glucose, liver and renal function markers, and blood lipids, were measured. SUA/SCr was calculated, and its association with TIR was analyzed.

Results

One-way ANOVA revealed significantly higher TIR levels in the SUA/SCrQ3 group compared to the Q1 group (72.90% [60.08%, 83.38%] vs. 80.20% [70.25%, 89.65%], p = 0.0084). Smooth curve fitting and threshold effect analyses demonstrated an inverted U-shaped association between SUA/SCr and TIR after multivariable adjustment. Before the inflection point (SUA/SCr = 6.471), a positive correlation was observed (β = 1.402, p = 0.0379), indicating a 1.402% increase in TIR per 1-unit increase in SUA/SCr. Beyond the inflection point, a negative correlation emerged (β = −4.406, p = 0.0043), corresponding to a 4.406% decrease in TIR per 1-unit increase in SUA/SCr. Trend tests confirmed the statistical significance of these bidirectional associations. Interaction analyses indicated that gender, BMI, GLP1RA-therapy, SGLT2i-therapy did not significantly modify the SUA/SCr-TIR association (p > 0.05 for all). However, age significantly modified this relationship (P for interaction = 0.0240). Subgroup analysis by age revealed a curvilinear association in participants aged < 65 years, with no significant association below the inflection point (SUA/SCr = 6.559; β = 0.796, p = 0.2803) but a significant negative association above it (β = −4.392, p = 0.0059). No significant association was found in participants aged ≥ 65 years.

Conclusions

An inverted U-shaped association exists between SUA/SCr and TIR in patients with T2DM, suggesting that maintaining SUA/SCr within a certain range may be a protective factor for TIR.

背景:血清尿酸(SUA)水平升高是代谢性疾病的重要标志。然而,SUA水平在很大程度上取决于肾脏清除功能。本研究旨在探讨2型糖尿病(T2DM)患者血清尿酸/肌酐(SUA/SCr)比值与时间范围(TIR)的相关性。方法:采用连续血糖监测(CGM)系统对514例住院T2DM患者的TIR进行评估。测定血糖、肝肾功能指标、血脂等生化指标。计算SUA/SCr,并分析其与TIR的相关性。结果:单因素方差分析显示,SUA/SCrQ3组的TIR水平显著高于Q1组(72.90%[60.08%,83.38%]对80.20% [70.25%,89.65%],p = 0.0084)。光滑曲线拟合和阈值效应分析表明,经多变量调整后,SUA/SCr与TIR呈倒u型相关。在拐点前(SUA/SCr = 6.471),二者呈正相关(β = 1.402, p = 0.0379),表明SUA/SCr每增加1单位,TIR增加1.402%。在拐点之外,出现负相关(β = -4.406, p = 0.0043),对应于SUA/SCr每增加1单位,TIR降低4.406%。趋势检验证实了这些双向关联的统计学意义。相互作用分析表明,性别、BMI、glp1ra治疗、sgltti治疗并没有显著改变SUA/SCr-TIR相关性(p < 0.05)。然而,年龄显著改变了这一关系(交互作用P = 0.0240)。结论:T2DM患者SUA/SCr与TIR呈倒u型相关,提示将SUA/SCr维持在一定范围内可能是TIR的保护因素。
{"title":"Association Between Serum Uric Acid to Creatinine Ratio and Time in Range in Patients With Type 2 Diabetes","authors":"Yu Gong,&nbsp;Ying Li,&nbsp;Qianqian Zhang,&nbsp;Zhangxiang Zhu,&nbsp;Guojuan Wang","doi":"10.1111/cen.70036","DOIUrl":"10.1111/cen.70036","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Elevated serum uric acid (SUA) levels are an important marker of metabolic disorders. However, SUA levels largely depend on renal clearance function. This study aims to investigate the correlation between serum uric acid to creatinine (SUA/SCr) ratio and time in range (TIR) in patients with type 2 diabetes mellitus (T2DM).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>TIR was assessed using continuous glucose monitoring (CGM) systems in 514 hospitalized patients with T2DM. Biochemical parameters, including blood glucose, liver and renal function markers, and blood lipids, were measured. SUA/SCr was calculated, and its association with TIR was analyzed.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>One-way ANOVA revealed significantly higher TIR levels in the SUA/SCrQ3 group compared to the Q1 group (72.90% [60.08%, 83.38%] vs. 80.20% [70.25%, 89.65%], <i>p</i> = 0.0084). Smooth curve fitting and threshold effect analyses demonstrated an inverted <i>U</i>-shaped association between SUA/SCr and TIR after multivariable adjustment. Before the inflection point (SUA/SCr = 6.471), a positive correlation was observed (<i>β</i> = 1.402, <i>p</i> = 0.0379), indicating a 1.402% increase in TIR per 1-unit increase in SUA/SCr. Beyond the inflection point, a negative correlation emerged (<i>β</i> = −4.406, <i>p</i> = 0.0043), corresponding to a 4.406% decrease in TIR per 1-unit increase in SUA/SCr. Trend tests confirmed the statistical significance of these bidirectional associations. Interaction analyses indicated that gender, BMI, GLP1RA-therapy, SGLT2i-therapy did not significantly modify the SUA/SCr-TIR association (<i>p</i> &gt; 0.05 for all). However, age significantly modified this relationship (<i>P</i> for interaction = 0.0240). Subgroup analysis by age revealed a curvilinear association in participants aged &lt; 65 years, with no significant association below the inflection point (SUA/SCr = 6.559; <i>β</i> = 0.796, <i>p</i> = 0.2803) but a significant negative association above it (<i>β</i> = −4.392, <i>p</i> = 0.0059). No significant association was found in participants aged ≥ 65 years.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>An inverted <i>U</i>-shaped association exists between SUA/SCr and TIR in patients with T2DM, suggesting that maintaining SUA/SCr within a certain range may be a protective factor for TIR.</p>\u0000 </section>\u0000 </div>","PeriodicalId":10346,"journal":{"name":"Clinical Endocrinology","volume":"103 5","pages":"682-691"},"PeriodicalIF":2.4,"publicationDate":"2025-09-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145063420","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Construction of a Personalized Prediction Model for Diabetic Lung Infection Based on Machine Learning 基于机器学习的糖尿病肺部感染个性化预测模型构建
IF 2.4 3区 医学 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-09-14 DOI: 10.1111/cen.70033
Qian Shen

Objective

This study aimed to develop and validate a clinical feature-based nomogram to predict the risk of lung infection in diabetic patients.

Methods

A total of 168 patients diagnosed with pulmonary infections at our hospital—comprising both diabetic and Nondiabetic individuals—were retrospectively enrolled and divided into a training cohort and an internal validation cohort. Feature selection was performed using the least absolute shrinkage and selection operator (LASSO) method, followed by multivariate logistic regression analysis to construct the predictive nomogram. Model performance was evaluated through calibration curves, receiver operating characteristic (ROC) analysis, and decision curve analysis (DCA) to assess predictive accuracy, calibration, and clinical utility, respectively.

Results

Multivariate analysis identified advanced age, male sex, abnormal neutrophil count, elevated glycated hemoglobin (HbA1c), and fasting plasma glucose (FPG) levels as independent risk factors for diabetic lung infection. A nomogram incorporating these variables and other clinically relevant predictors was constructed. The area under the ROC curve (AUC) was 0.919 (95%CI: 0.825–0.937) in the training set and 0.862 (95% CI: 0.819–0.912) in the validation set, indicating strong discriminative ability. Calibration curves demonstrated good agreement between predicted and observed outcomes. DCA confirmed the nomogram's clinical value across a wide range of threshold probabilities.

Conclusion

We developed a robust and clinically applicable nomogram for predicting the risk of pneumonia in diabetic patients with pulmonary infections. This model exhibits high accuracy and may assist clinicians in identifying high-risk individuals who could benefit from early preventive measures and timely interventions.

目的:本研究旨在建立并验证一种基于临床特征的nomogram预测糖尿病患者肺部感染风险的方法。方法:回顾性纳入我院诊断为肺部感染的168例患者(包括糖尿病和非糖尿病患者),并将其分为训练队列和内部验证队列。采用最小绝对收缩和选择算子(LASSO)方法进行特征选择,然后进行多元逻辑回归分析,构建预测模态图。通过校准曲线、受试者工作特征(ROC)分析和决策曲线分析(DCA)评估模型的性能,分别评估预测准确性、校准和临床实用性。结果:多因素分析发现,高龄、男性、中性粒细胞计数异常、糖化血红蛋白(HbA1c)升高和空腹血糖(FPG)水平是糖尿病肺部感染的独立危险因素。结合这些变量和其他临床相关预测因子构建了一个nomogram。训练集的ROC曲线下面积(AUC)为0.919 (95%CI: 0.825-0.937),验证集的AUC为0.862 (95%CI: 0.819-0.912),判别能力较强。校正曲线显示预测结果与观测结果吻合良好。DCA在广泛的阈值概率范围内证实了nomogram临床价值。结论:我们开发了一种可靠且临床适用的nomogram预测糖尿病合并肺部感染患者发生肺炎的风险。该模型具有很高的准确性,可以帮助临床医生识别高危人群,这些人可以从早期预防措施和及时干预中受益。
{"title":"Construction of a Personalized Prediction Model for Diabetic Lung Infection Based on Machine Learning","authors":"Qian Shen","doi":"10.1111/cen.70033","DOIUrl":"10.1111/cen.70033","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objective</h3>\u0000 \u0000 <p>This study aimed to develop and validate a clinical feature-based nomogram to predict the risk of lung infection in diabetic patients.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>A total of 168 patients diagnosed with pulmonary infections at our hospital—comprising both diabetic and Nondiabetic individuals—were retrospectively enrolled and divided into a training cohort and an internal validation cohort. Feature selection was performed using the least absolute shrinkage and selection operator (LASSO) method, followed by multivariate logistic regression analysis to construct the predictive nomogram. Model performance was evaluated through calibration curves, receiver operating characteristic (ROC) analysis, and decision curve analysis (DCA) to assess predictive accuracy, calibration, and clinical utility, respectively.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Multivariate analysis identified advanced age, male sex, abnormal neutrophil count, elevated glycated hemoglobin (HbA1c), and fasting plasma glucose (FPG) levels as independent risk factors for diabetic lung infection. A nomogram incorporating these variables and other clinically relevant predictors was constructed. The area under the ROC curve (AUC) was 0.919 (95%CI: 0.825–0.937) in the training set and 0.862 (95% CI: 0.819–0.912) in the validation set, indicating strong discriminative ability. Calibration curves demonstrated good agreement between predicted and observed outcomes. DCA confirmed the nomogram's clinical value across a wide range of threshold probabilities.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>We developed a robust and clinically applicable nomogram for predicting the risk of pneumonia in diabetic patients with pulmonary infections. This model exhibits high accuracy and may assist clinicians in identifying high-risk individuals who could benefit from early preventive measures and timely interventions.</p>\u0000 </section>\u0000 </div>","PeriodicalId":10346,"journal":{"name":"Clinical Endocrinology","volume":"103 6","pages":"815-822"},"PeriodicalIF":2.4,"publicationDate":"2025-09-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145063427","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Thyroid Hormones Correlate to the Therapeutic Effect of Ovulation Induction in Infertile Women With Polycystic Ovary Syndrome 甲状腺激素与多囊卵巢综合征不孕妇女促排卵治疗效果的关系。
IF 2.4 3区 医学 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-09-09 DOI: 10.1111/cen.70030
Xuefei Hao, Shasha Liu, Hanjing Zheng, Qiuchen Wang, Lizhen Jin, Jing Ma

Background

Polycystic ovary syndrome (PCOS) is a prevalent endocrine and metabolic disorder affecting 5%–10% of reproductive-age women, accounting for 50%–70% of anovulatory infertility. Thyroid function, particularly the relationship between subclinical hypothyroidism (SCH) and PCOS, has garnered attention due to its potential impact on metabolic and reproductive health.

Methods

This study included 143 infertile women with PCOS diagnosed based on the Rotterdam criteria. Participants underwent ovulation induction using clomiphene citrate following pretreatment with Diane-35. Serum levels of triiodothyronine (T3), thyroxine (T4), and thyroid-stimulating hormone (TSH) were measured pre- and posttherapy. Outcomes were compared between therapy-responsive (n = 97) and nonresponsive (n = 46) groups. Receiver operating characteristic (ROC) analysis evaluated the predictive value of T3, T4, and TSH levels for treatment outcomes.

Results

Significant differences in baseline T3, T4, and TSH levels were observed between responsive and nonresponsive groups (p < 0.001). Posttreatment, serum T3 and T4 increased while TSH decreased in the responsive group, whereas no significant changes were noted in the nonresponsive group. Combined ROC analysis of T3, T4, and TSH improved predictive accuracy (AUC = 0.88, sensitivity = 76.09%, specificity = 86.60%). Endometrial thickness positively correlated with T3 and T4 and negatively with TSH.

Conclusions

Thyroid hormones significantly influence the efficacy of ovulation induction in infertile women with PCOS. Combined T3, T4, and TSH measurements enhance predictive accuracy for therapeutic responses, providing a foundation for personalized treatment strategies.

背景:多囊卵巢综合征(PCOS)是一种常见的内分泌和代谢疾病,影响5%-10%的育龄妇女,占无排卵性不孕的50%-70%。甲状腺功能,特别是亚临床甲状腺功能减退症(SCH)与多囊卵巢综合征(PCOS)之间的关系,由于其对代谢和生殖健康的潜在影响而引起了人们的关注。方法:本研究纳入143例根据鹿特丹标准诊断为PCOS的不孕妇女。参与者在Diane-35预处理后使用克罗米芬柠檬酸诱导排卵。测定治疗前后血清三碘甲状腺原氨酸(T3)、甲状腺素(T4)、促甲状腺激素(TSH)水平。比较治疗反应组(n = 97)和无反应组(n = 46)的结果。受试者工作特征(ROC)分析评估T3、T4和TSH水平对治疗结果的预测价值。结果:反应组和无反应组的基线T3、T4和TSH水平有显著差异(p)。结论:甲状腺激素显著影响PCOS不孕妇女的促排卵效果。T3、T4和TSH联合测量提高了治疗反应预测的准确性,为个性化治疗策略提供了基础。
{"title":"Thyroid Hormones Correlate to the Therapeutic Effect of Ovulation Induction in Infertile Women With Polycystic Ovary Syndrome","authors":"Xuefei Hao,&nbsp;Shasha Liu,&nbsp;Hanjing Zheng,&nbsp;Qiuchen Wang,&nbsp;Lizhen Jin,&nbsp;Jing Ma","doi":"10.1111/cen.70030","DOIUrl":"10.1111/cen.70030","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Polycystic ovary syndrome (PCOS) is a prevalent endocrine and metabolic disorder affecting 5%–10% of reproductive-age women, accounting for 50%–70% of anovulatory infertility. Thyroid function, particularly the relationship between subclinical hypothyroidism (SCH) and PCOS, has garnered attention due to its potential impact on metabolic and reproductive health.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>This study included 143 infertile women with PCOS diagnosed based on the Rotterdam criteria. Participants underwent ovulation induction using clomiphene citrate following pretreatment with Diane-35. Serum levels of triiodothyronine (T3), thyroxine (T4), and thyroid-stimulating hormone (TSH) were measured pre- and posttherapy. Outcomes were compared between therapy-responsive (<i>n</i> = 97) and nonresponsive (<i>n</i> = 46) groups. Receiver operating characteristic (ROC) analysis evaluated the predictive value of T3, T4, and TSH levels for treatment outcomes.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Significant differences in baseline T3, T4, and TSH levels were observed between responsive and nonresponsive groups (<i>p</i> &lt; 0.001). Posttreatment, serum T3 and T4 increased while TSH decreased in the responsive group, whereas no significant changes were noted in the nonresponsive group. Combined ROC analysis of T3, T4, and TSH improved predictive accuracy (AUC = 0.88, sensitivity = 76.09%, specificity = 86.60%). Endometrial thickness positively correlated with T3 and T4 and negatively with TSH.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>Thyroid hormones significantly influence the efficacy of ovulation induction in infertile women with PCOS. Combined T3, T4, and TSH measurements enhance predictive accuracy for therapeutic responses, providing a foundation for personalized treatment strategies.</p>\u0000 </section>\u0000 </div>","PeriodicalId":10346,"journal":{"name":"Clinical Endocrinology","volume":"104 2","pages":"152-159"},"PeriodicalIF":2.4,"publicationDate":"2025-09-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145029016","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Clinical Endocrinology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1